Recently, Department of Virology Institute of Tropical Medicine Nagasaki University, a WHO collaborating centre, delivered an evaluation of Wondfo Finecare™ Dengue NS1 Antigen test kit. As the evaluations shows, Finecare™ Dengue NS1 Ag test kit (immunofluorescence) enjoys excellent performance and can be of great help in controlling dengue fever.
96% Sensitivity Compared to qRT-PCR
As a WHO collaborating centre for reference and research on tropical and emerging virus diseases, Department of Virology Institute of Tropical Medicine Nagasaki University conducts basic and applied research on arthropod-borne （arbo） viruses; such as Japanese encephalitis virus, dengue virus, Zika virus, chikungunya virus, severe fever with thrombocytopenia syndrome （SFTS） virus, and highly pathogenic viruses; filoviruses and novel coronaviruses.
In January 2023, the Department conducted an evaluation of Wondfo Finecare™ Dengue NS1 Antigen test kit (immunofluorescence) with comparison to dengue RT-PCR positive 50 serum samples. It concludes that the sensitivity of Wondfo Finecare™ Dengue NS1 Ag Test is 96% and highly correlated with standard quantitative real time RT-PCR test.
Focused in POCT, Finecare Strives for Easier Healthcare
As early as 2009, Wondfo launched the first quantitative fluorescence immunoassay detecting system, Finecare™ FIA Meters together with inflammation markers, cardiac markers and other test items gradually launched. With the advantages of a comprehensive reagent panel, sample compatibility of whole blood/plasma/serum, and simultaneous detection of multiple items, more than 20,000 units of Wondfo Finecare™ FIA Meters have been installed in China and over 50,000 units in more than 100 countries and regions overseas.
Finecare™ FIA Meters and reagents have been widely applied in various clinical scenarios such as laboratory, emergency, ICU, and cardiology. At present, Finecare™ FIA Meters enable an extensive portfolio of 50+ test items covering a highly comprehensive series of categories.
For Health of Mankind, Facilitating Global Healthcare with Technologies
In 2016, a year characterized by large dengue outbreaks worldwide, Wondfo developed and launched the first test kit for Dengue NS1 Ag test kit (colloidal gold). Up to now, Wondfo has launched dengue antigen and antibody tests on multiple platforms such as platforms of colloidal gold, immunofluorescence and chemiluminescence immunoassay. These test items gradually launched have been widely applied in multiple countries and regions to control the transmission.
From SARS, Flu A&B, H7N9 to COVID-19, Wondfo has been actively engaged in fighting with global pandemics and has been contributed to public healthcare worldwide. We remain unswerving to provide the public with cutting-edge technology and products and improve diagnosis with rapid tests. Racing for Life.